Paul Riley/LinkedIn
Jul 18, 2026, 11:54
Paul Riley: Presenting STAR Max3 at ISTH 2026
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared a post on LinkedIn:
“Showing our FDA submission data for the STAR Max3 at ISTH – always a privilege to attend and present at ISTH, with this meeting especially meaningful because it is taking place in Paris, the location for my first ISTH 25 years ago!
A quarter century of being witness to all of the change in the field and also International Society on Thrombosis and Haemostasis (ISTH)‘s growth as an organization clinical laboratory wtd2026.
I really do feel privileged to be involved with ISTH during these times.
I will miss Paris but will make it back soon enough.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Oct 17, 2026, 12:21Jalen Hurts Sidelined by a Superficial Blood Clot: What to Know
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries